MedTechShowcase_booklet by davidzaharoff

MEDTECH SHOWCASE

NC Biotechnology Center April 30, 2024

6 to 9 PM

Schedule of Events

6:00 - 6:15 PM

6:15 - 6:40 PM

6:40 - 7:05 PM

7:05 - 7:55 PM

8:00 - 8:25 PM

8:25 - 8:50 PM

8:50 - 9:00 PM

Welcome

Adaptive Limb Solutions Tether Medical

Break/Mixer Florasense Centum Medical Awards

Special Thanks

The Class of 2024 would like to thank their clinical mentors, guest speakers, and collaborators!

The faculty would like to thank Laura Schranz, BME Director of Development and Yvette Thompson, BME Program Specialist for making this Showcase a reality!!

John Hayes

Matt Penny

Tim Martin

MedTech Faculty

Nick Jardine

David Zaharoff

Guest Judges

George L. Adams, MD, MHS, MBA, FACC

Dr. George L. Adams is a world-renowned interventional cardiologist and leading pioneer in vascular interventions. He is the Director of Cardiovascular and Peripheral Vascular Research at UNC Rex overseeing more than 60 active studies. Dr. Adams is also an Associate Professor of Cardiology in the UNC School of Medicine. In addition, Dr. Adams is the Chief Medical Officer of Cordis Medical.

Nicole Bell, MBA

Ms. Bell is the Chief Business Officer of Galaxy Diagnostics, Inc. She was previously an executive in engineering and new product development for over ten years in young and growth-stage companies, including TransEnterix, where she served as VP, R&D, driving the development of a surgical robot from breadboard design to FDA submission in 3 years, propelling the company’s market cap to over $500M. Ms. Bell is also a best-selling author.

Peter C. Johnson, MD

Dr. Peter C. Johnson is a retired plastic surgeon, serial entrepreneur, artist, and farmer. He is the former CEO and current Chairman of the Board at CellX Technologies. Dr. Johnson is a Co-Founder and Partner of Oxford Oaks Distillery and Verdigris Restaurant and sole founder & CEO of Scintellix, LLC. He founded the Pittsburgh Tissue Engineering Initiative and has held roles as co-founder/CEO of Tissue Informatics, CMO/ CBO of Icoria, EVP of Entegrion, and VP, R&D and Medical Affairs of Vancive Medical Technologies.

A. Travis Manasco, MD

Dr. Travis Manasco is a board-certified critical care and emergency medicine physician at WakeMed Hospitals and an Adjunct Assistant Professor at the UNC School of Medicine. He is co-founder and CMO at Bio 54 and was previously co-founder and CEO at Alacrity Medical Innovations. Dr. Manasco is also a Principal at Solas Bioventures.

Adaptive Limb Solutions, LLC aims to develop products that help to benefit procedures within the field of orthopaedic surgery. Our first device is designed with total shoulder replacement in mind, and aims to limit the amount of hands and personnel within the room during the operation. We hope to expand into other joints in the future.

At Tether Medical, we are focused on bringing cutting edge technology in the software and hardware arena that will help severely understaffed ICU nurses save time, stress, and patient lives. Our solution aims to automate the administration of vasopressor medication delivery. Through a closed-loop control, we plan to connect the blood pressure monitor and IV pump to allow for continuous blood pressure monitoring and real-time adjustments to vasopressor medication. We are seeking $100,000 to continue developing the Nyquist product and patent our design.

Audrey George aegeorg2@ncsu.edu

Cameron Pirozzi copirozz@ncsu.edu

Alex

ajshaff2@ncsu.edu

William Wyman wfwyman@ncsu.edu

Shaffer

The FloraSense DermaGuard is revolutionizing the management of chronic wounds by providing a smartphone-enabled, wearable smart bandage. This innovative technology allows both patients and healthcare professionals to monitor the bacterial conditions of wounds in real-time. Our commitment stems from a deep passion for the diabetic community, which is disproportionately impacted by chronic infections. We are seeking $40,000 to further our research and development, enhance our sensors, and initiate preparations for preclinical trials.

Hunter Faulkner hfaulkn@ncsu.edu

Alana Howell abhowell@ncsu.edu

Daniela Martinez Leal dbmarti2@ncsu.edu

Centum Medical is improving peripheral chronic total occlusion (CTO) treatment outcomes via a novel mechanism for trans-lesion guidewire delivery. The Vanguard crossing catheter combines standard rotary drilling with specialized oscillation to target calcified plaque and thrombus, while leaving the vessel walls intact. The Vanguard crossing catheter eliminates the need for vessel reentry devices and lowers the risk of vessel perforations and scarring, providing a safer treatment option for patients with few alternatives. We are currently seeking clinical and industry contacts from leaders in the cardiovascular and interventional radiology space to provide feedback on our phase 1 prototype.